Ambulatory Medication Change Workflows' Effect on Communication to Pharmacies
Applied Clinical Informatics · 01.03.2025 · 16 (02) · 472-476
DOI: 10.1055/a-2518-0194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Clinical Informatics, erschienen am 01.03.2025. Verfasst von Samantha I Pitts und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States. Hauptthemen laut MEDLINE: Workflow, Pharmacies, Communication, Ambulatory Care. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
When implemented in both electronic health records (EHRs) and pharmacy management software, CancelRx communicates medication discontinuation in the EHR to pharmacies, which has been demonstrated to reduce medication discrepancies at pharmacies and the risk of medication dispensing after e-prescription discontinuation. Provider workflows for making medication changes and the configuration of CancelRx will affect whether a medication change (e.g., dose adjustment) is communicated to a pharmacy.
Objective
This study aimed to assess the effect of CancelRx configuration and the EHR tools used in provider workflows for medication changes on notification to health system and external community pharmacies.
Methods
We conducted a functionality analysis of prescriber workflows for documenting a medication change using “change,” “reorder,” “adjust sig,” “discontinue,” and “taking differently.” In the EHR test environment, we examined three outcomes of interest: communication of discontinuation of the old prescription (or cancellation); generation of a new prescription; and instructions to the patient. Results “Change” was the only single-step function that communicated medication discontinuation to both health system and external community pharmacies with default settings, although “discontinue” followed by a new prescription had the same results. “Reorder” and “adjust sig” functions had different cancellation outcomes for internal and external community pharmacies. “Adjust sig” also had different prescribing outcomes for internal and external pharmacies and “taking differently” did not result in communication of discontinuation or a new prescription at either pharmacy type.
Conclusion
Several workflows for dose changes did not communicate to external community pharmacies, resulting in different prescriptions at the health system and external community pharmacies. Health systems leaders should consider the implications of local EHR workflows and CancelRx configuration on communication of medication changes to pharmacies as part of CancelRx implementation. Multidisciplinary collaboration is needed to develop more effective strategies for communication of medication dose changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
- Johns Hopkins Care at Home, Johns Hopkins Medicine, Baltimore, Maryland, United States.
- Johns Hopkins Armstrong Institute, Johns Hopkins Medicine, Baltimore, Maryland, United States.
- Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Zitieren
APA
Pitts, S. I., Thomas, B., Yang, Y., & Chen, A. R. (2025). Ambulatory Medication Change Workflows' Effect on Communication to Pharmacies. Applied Clinical Informatics, 16(02), 472-476. https://doi.org/10.1055/a-2518-0194
Vancouver
Pitts SI, Thomas B, Yang Y, Chen AR. Ambulatory Medication Change Workflows' Effect on Communication to Pharmacies. Applied Clinical Informatics. 2025;16(02):472-476. doi:10.1055/a-2518-0194
BibTeX
@article{Pitts2025,
author = {Pitts, Samantha I and Thomas, Bridgette and Yang, Yushi and Chen, Allen R},
title = {Ambulatory Medication Change Workflows' Effect on Communication to Pharmacies},
journal = {Applied Clinical Informatics},
year = {2025},
volume = {16},
number = {02},
pages = {472--476},
doi = {10.1055/a-2518-0194}
}
EUVIMED